| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 48.872 | 48.137 | 48.138 | 62.494 | 61.189 | 61.461 | 60.301 | 59.142 | 58.926 | - |
| Total Income - EUR | 48.872 | 48.137 | 48.138 | 62.494 | 70.250 | 69.731 | 60.301 | 66.040 | 75.640 | - |
| Total Expenses - EUR | 42.828 | 52.291 | 57.148 | 64.416 | 69.432 | 68.062 | 40.725 | 60.748 | 68.204 | - |
| Gross Profit/Loss - EUR | 6.044 | -4.154 | -9.010 | -1.922 | 818 | 1.669 | 19.577 | 5.292 | 7.436 | - |
| Net Profit/Loss - EUR | 4.578 | -4.867 | -9.496 | -2.545 | 148 | 1.015 | 18.937 | 4.600 | 6.747 | - |
| Employees | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | - |
Check the financial reports for the company - Bat Bio Coriali S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 19.219 | 21.719 | 15.224 | 13.105 | 18.320 | 17.765 | 29.127 | 1.346 | 12.671 | - |
| Inventories | 19.028 | 21.570 | 14.886 | 12.583 | 17.823 | 16.601 | 28.838 | 980 | 11.259 | - |
| Receivables | 0 | 0 | 0 | 0 | 48 | 0 | 284 | 285 | 166 | - |
| Cash | 191 | 149 | 338 | 522 | 449 | 1.164 | 4 | 81 | 1.246 | - |
| Shareholders Funds | -15.986 | -20.690 | -29.836 | -31.833 | -31.069 | -29.465 | -9.874 | -5.305 | 1.458 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 35.205 | 42.409 | 45.060 | 44.938 | 49.389 | 47.230 | 39.001 | 6.651 | 11.213 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Bat Bio Coriali S.r.l.